Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Oficinas extranjeras
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Divisiones operativas
      • División de Aviación
      • División de Control de Desvíos
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Lo que hacemos
    • Orden público
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Educación y prevención
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Información sobre las drogas
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Carreras
    • Agentes especiales
      • Preguntas frecuentes de los agentes especiales
      • Anuncios de empleo para agentes especiales
    • Investigador de desvíos
      • Diversion Investigator Job Announcement
    • Especialista en investigación de inteligencia
      • Anuncios de trabajo de especialista en investigación de inteligencia
      • Preguntas frecuentes de los especialistas en investigación de inteligencia
      • Autoridad de contratación de la Categoría A: Especialista en investigación de inteligencia
    • Carreras de ciencias forenses
    • Carreras profesionales y administrativas
    • Carreras para estudiantes y de nivel básico
    • Cómo aplicar
      • Empleador con igualdad de oportunidades
      • Requisitos de empleo
      • Cómo reclamar la preferencia de los veteranos
      • Consideración prioritaria
      • Beneficios
      • Veteranos y personas con discapacidades
  • Recursos
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Buscar
  • Menú Completo

Main Menu

  • Quiénes somos
  • Lo que hacemos
  • Carreras
  • Recursos
  • Recibir Actualizaciones
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Frank A. Tarentino III Special Agent in Charge
New York
@DEANewYorkDiv
Octubre 13, 2022
Contact:
Phone Number: (212) 337-3900
For Immediate Release

Eight Defendants, Including a Brooklyn Medical Doctor, And Three Pharmacists, Charged with Illegally Distributing More Than 1.2 Million Oxycodone Pills

Defendants Allegedly Conspired to Divert Oxycodone Worth at Least $24 Million

BROOKLYN, NY – Earlier today, in federal court in Brooklyn, a 10-count indictment was unsealed charging Dr. Somsri Ratanaprasatporn, her office manager Leticia Smith, Bassam Amin, Omar Elsayed, and Yousef Ennab who are pharmacists, Michael Kent, Anthony Mathis, and Raymond Walker with conspiracy to distribute and possess with intent to distribute oxycodone and related crimes. Smith and Kent are also charged with money laundering in connection with their alleged efforts to hide the proceeds of their illegal oxycodone distribution operation. All eight defendants were arrested this morning and are scheduled to be arraigned this afternoon before United States Magistrate Judge Robert M. Levy.

Breon Peace, United States Attorney for the Eastern District of New York; Frank A. Tarentino, Special Agent in Charge, Drug Enforcement Administration, New York Division (DEA); Elysia M. Doherty, Assistant Special Agent-in-Charge, U.S. Department of Health and Human Services, Office of Inspector General’s Office of Investigations, New York Region (HHS-OIG); Thomas M. Fattorusso, Special Agent-in-Charge, Internal Revenue Service Criminal Investigations, New York (IRS-CI); Keechant L. Sewell, Commissioner, New York City Police Department (NYPD); Jocelyn E. Strauber, Commissioner, New York City Department of Investigation (DOI); and Joshua Vinciguerra, Director, New York State Department of Health, Bureau of Narcotic Enforcement (BNE), announced the charges.

“Doctors and medical professionals have a professional obligation to do no harm, but, as alleged, the defendants callously supplied more than one million pills to traffickers for distribution, resulting in dangerous opioids flooding the streets of this district,” stated United States Attorney Peace. “Today’s charges demonstrate this Office’s continued commitment to stemming the availability of illegal drugs and holding to account those who contribute to the epic tragedy that is the opioid epidemic.”

“This structured drug trafficking ring’s operations started in a doctor’s office and ended with $24 million worth of diverted oxycodone on the streets,” stated DEA Special Agent in Charge Tarentino.  “DEA and our law enforcement partners will continue to hold DEA Registrants and other medical professionals to the highest possible standards and also hold them accountable when they knowingly endanger members of the community. Together, we are all proud of this righteous work, and for the difference it makes in our communities. I commend the investigators and the prosecution team for their work on this wide-spread investigation.”

“As alleged, our health care system that serves vulnerable populations has been undermined by these individuals,” stated HHS-OIG Assistant Special Agent-in-Charge Doherty. “HHS-OIG, together with our law enforcement partners, will continue to vigorously pursue those who steal from government health care programs for personal gain.” NYPD Commissioner Sewell stated: “Today’s charges prove again that our fight against the illegal drug trade is unremitting. The NYPD, together with all of our local, state, and federal law-enforcement partners, will pursue these criminals wherever they operate – and when the perpetrators are trusted members of the medical community, their crimes are especially egregious. I thank and commend the U.S. Attorney’s Office for the Eastern District of New York, the DEA’s New York Division, the Office of the Inspector General of the U.S. Department of Health and Human Services, the Internal Revenue Services’ Criminal Investigations, the NYS Department of Health’s Bureau of Narcotic Enforcement, the New York City Department of Investigation, and everyone else involved in this case for their exceptional work.”

“As charged, these defendant medical professionals and their co-conspirators supplied more than 1.2 million oxycodone pills to the streets of New York City, promoting the illicit trade of dangerously addictive opioids. DOI will continue to work tirelessly with our federal and law enforcement partners to ensure that pill mills such as this one are exposed and shut down, and that the individuals who run them are held accountable. I thank the United States Attorney’s Office for the Eastern District of New York and all our investigative partners on this investigation,” stated DOI Commissioner Strauber.

“With this multi-million-dollar criminal scheme, it's alleged the defendants made their profits off the vulnerabilities and addictions of their customers throughout New York City. Law enforcement partnerships like those seen here today have been and continue to be an integral part of stopping the flow of highly addictive narcotics into our communities,” stated IRS-CI Special Agent-in-Charge Fattorusso.

“Today’s charges show how diverted prescription drugs still fuel the opioid epidemic in New York. The Bureau of Narcotic Enforcement remains resolute in its commitment to work together with our federal and local law enforcement partners to disrupt and dismantle the criminal organizations that abuse the public’s trust in health care practitioners to move these dangerous and addictive pills from pharmacies to our neighborhoods,” stated BNE Director Vinciguerra.

Oxycodone is a highly addictive opioid used to treat severe and chronic pain conditions. Every year, millions of Americans abuse oxycodone, and the misuse of prescription painkillers like oxycodone leads to hundreds of thousands of annual emergency room visits. More than 16,000 Americans died from prescription opioid overdoses in 2020. Oxycodone prescriptions have enormous cash value to drug dealers. For example, one oxycodone 30 mg tablet, which was the dosage prescribed in this case, can be sold by dealers on the street for between $20 and $30 in New York City.

As set forth in the indictment and publicly filed documents, between December 2018 and October 2022, the defendants operated a drug distribution ring out of a medical practice on Linden Boulevard in East New York, Brooklyn. Together, they unlawfully distributed more than 11,000 prescriptions for oxycodone, amounting to more than 1.2 million oxycodone pills, which carry a street value of at least $24 million. Ratanaprasatporn, a pediatrician and general practitioner, and Smith, issued the prescriptions; Amin, Ennab and Elsayed filled the prescriptions at pharmacies in Brooklyn and Staten Island, and Kent, Mathis, and Walker oversaw “crews” of sham patients who received medically unnecessary prescriptions. Together, the defendants made millions of dollars from the scheme. During the execution of a search warrant this morning, members of law enforcement recovered several hundred thousand dollars in U.S. currency from Smith’s residence. Law enforcement also recovered two handguns that Kent was observed tossing from a rear door of his residence.

If convicted of the drug charges, the defendants face up to 20 years’ imprisonment. If convicted of the money laundering charges, Smith and Kent face up to 20 years’ imprisonment for each count. The charges in the indictment are allegations, and the defendants are presumed innocent unless and until proven guilty.

The charges are the result of an ongoing Organized Crime Drug Enforcement Task Forces (OCDETF) investigation led by the United States Attorney’s Office for the Eastern District of New York and the DEA. The principal mission of the OCDETF program is to identify, disrupt, and dismantle the most serious drug trafficking, weapons trafficking, and money laundering organizations, and those primarily responsible for the nation’s illegal drug supply. OCDETF uses a prosecutor-led, intelligence-driven, multi-agency approach that leverages the strengths of federal, state, and local law enforcement agencies against criminal networks.

The government’s case is being prosecuted by Assistant United States Attorneys Laura Zuckerwise, Victor Zapana, and Gilbert Rein. Assistant United States Attorney Claire Kedeshian of the Office’s Asset Recovery Section is handling forfeiture matters.

New Yorkers who need help finding substance-use-disorder treatment resources should contact 1-877-8-HOPENY. The HopeLine provides high quality, responsive information, and referral services via phone and text message to callers throughout New York State experiencing substance abuse issues. HOPEline services are free and confidential.

The Defendants:    
LETICIA SMITH Age: 54 Brooklyn, New York
BASSAM AMIN Age: 69 Brooklyn, New York
OMAR ELSAYED Age: 28 Hackensack, New Jersey
YOUSEF ENNAB Age: 25 Brooklyn, New York
MICHAEL KENT Age: 49 Brooklyn, New York
ANTHONY MATHIS Age: 55 New Windsor, New York
DR. SOMSRI RATANAPRASATPORN Age: 75 Staten Island, New York
RAYMOND WALKER Age: 70 Brooklyn, New York

E.D.N.Y. Docket No. 22-CR464 (DLI)

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Divisiones Nacionales
    • Oficinas Extranjeras
    • Contáctenos
    • Museo DEA
  • Lo Que Hacemos
    • Prevención de Drogas
    • Aplicacion de la Ley
    • División de Control de Desvío
    • Noticias
  • Carreras
    • Resumen
    • Agente Especial
    • Investigador de Desvío
    • Especialista en Investigación de Inteligencia
  • Recursos
    • Información sobre las Drogas
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster